The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Global Disparities of Cancer and Its Projected Burden in 2050
Open accessAbstract
Importance: Cancer prevention and care efforts have been challenged by the COVID-19 pandemic and armed conflicts, resulting in a decline in the global Human Development Index (HDI), particularly in low- and middle-income countries. These challenges and subsequent shifts in health care priorities underscore the need to continuously monitor cancer outcome disparities and statistics globally to ensure delivery of equitable and optimal cancer prevention and care in uncertain times. Objective: To measure the global burden of 36 cancers in 2022 by sex, age, and geographic location and to project future trends by 2050. Design, Setting, and Participants: This cross-sectional study used population-based data from 2022 in 185 countries and territories were obtained from the Global Cancer Observatory database. Data extraction and analysis were carried out in April 2024. Main Outcomes and Measures: Counts, rates, prevalence, mortality to incidence ratios (MIRs), and demography-based projections were used to characterize current and future cancer burden. Results: This population-based study included 36 cancer types from 185 countries and territories. By 2050, 35.3 million cancer cases worldwide are expected, a 76.6% increase from the 2022 estimate of 20 million. Similarly, 18.5 million cancer deaths are projected by 2050, an 89.7% increase from the 2022 estimate of 9.7 million. Cancer cases and deaths are projected to nearly triple in low-HDI countries by 2050, compared to a moderate increase in very high–HDI countries (142.1% vs 41.7% for cancer cases and 146.1% vs 56.8% for cancer deaths). Males had a higher incidence and greater number of deaths in 2022 than females, with this disparity projected to widen by up to 16.0% in 2050. In 2022, the MIR for all cancers was 46.6%, with higher MIRs observed for pancreatic cancer (89.4%), among males (51.7%), among those aged 75 years or older (64.3%), in low-HDI countries (69.9%), and in the African region (67.2%). Conclusions and Relevance: In this cross-sectional study based on data from 2022, cancer disparities were evident across HDI, geographic regions, age, and sex, with further widening projected by 2050. These findings suggest that strengthening access to and quality of health care, including universal health insurance coverage, is key to providing evidence-based cancer prevention, diagnostics, and care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
International Agency for Research on Cancer
National Cancer Institute (2020) · Definitions · doi:10.32388/pfg7jq · Cited by 9,435
Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Cancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 5,689
The United Nations Development Programme
Oestreich, J. E. (2017) · Development and Human Rights · doi:10.1093/acprof:oso/9780190637347.003.0003 · Cited by 4,894
Current and future burden of breast cancer: Global statistics for 2020 and 2040
Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., Vignat, J., Gralow, J. R., Cardoso, F., Siesling, S., et al. (2022) · The Breast · doi:10.1016/j.breast.2022.08.010 · Cited by 3,411
Global Burden of Disease 2019 Cancer Collaboration, Kocarnik, J. M., Compton, K., Dean, F. E., Fu, W., Gaw, B. L., Harvey, J. D., Henrikson, H. J., Lu, D., Pennini, A., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2021.6987 · Cited by 2,026
Self-citationCancer survival in five continents: a worldwide population-based study (CONCORD)
Coleman, M. P., Quaresma, M., Berrino, F., Lutz, J.-M., De Angelis, R., Capocaccia, R., Baili, P., Rachet, B., Gatta, G., Hakulinen, T., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70179-7 · Cited by 1,002
Dai, X., Gakidou, E., & Lopez, A. D. (2022) · Tobacco Control · doi:10.1136/tobaccocontrol-2021-056535 · Cited by 535
Changes in colorectal cancer incidence in seven high-income countries: a population-based study
Araghi, M., Soerjomataram, I., Bardot, A., Ferlay, J., Cabasag, C. J., Morrison, D. S., De, P., Tervonen, H., Walsh, P. M., Bucher, O., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30147-5 · Cited by 479
Sharma, R. (2022) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-02108-2 · Cited by 265
The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival
Asadzadeh Vostakolaei, F., Karim-Kos, H. E., Janssen-Heijnen, M. L. G., Visser, O., Verbeek, A. L. M., & Kiemeney, L. A. L. M. (2011) · European Journal of Public Health · doi:10.1093/eurpub/ckq120 · Cited by 230
Health Promotion in Health Care – Vital Theories and Research
(2021) · Springer eBooks · doi:10.1007/978-3-030-63135-2 · Cited by 169
Redefining meaningful age groups in the context of disease
Geifman, N., Cohen, R., & Rubin, E. (2013) · AGE · doi:10.1007/s11357-013-9510-6 · Cited by 132
Bizuayehu, H. M., Dadi, A. F., Abate, K. H., Ketema, D. B., Ahmed, K. Y., Kassa, Z. Y., Amsalu, E. T., Kibret, G. D., Alemu, A. A., Alebel, A., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34809 · Cited by 88
Self-citationNyandekwe, M., Nzayirambaho, M., & Kakoma, J. B. (2020) · Pan African Medical Journal · doi:10.11604/pamj.2020.37.55.20376 · Cited by 77
Cancer Prevention in Low-Resource Countries: An Overview of the Opportunity
Kamaraju, S., Drope, J. M., Sankaranarayanan, R., & Shastri, S. S. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_280625 · Cited by 75
Recent Mortality Patterns and Time Trends for the Major Cancers in 47 Countries Worldwide
Sedeta, E. T., Sung, H., Laversanne, M., Bray, F., & Jemal, A. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-1133 · Cited by 74
Cancer and aging: Epidemiology and methodological challenges
Pedersen, J. K., Engholm, G., Skytthe, A., & Christensen, K. (2016) · Acta Oncologica · doi:10.3109/0284186x.2015.1114670 · Cited by 68
Amini, M., Looha, M. A., Zarean, E., & Pourhoseingholi, M. A. (2022) · BMC Public Health · doi:10.1186/s12889-022-12867-w · Cited by 64
Villain, P., Carvalho, A. L., Lucas, E., Mosquera, I., Zhang, L., Muwonge, R., Selmouni, F., Sauvaget, C., Basu, P. S., & for the IARC COVID‐19 Impact Study Group (2021) · International Journal of Cancer · doi:10.1002/ijc.33500 · Cited by 59
Eberth, J. M., Zahnd, W. E., Adams, S. A., Friedman, D. B., Wheeler, S. B., & Hébert, J. R. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105849 · Cited by 39
Li, J. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i1.278 · Cited by 35
Enhancing Cancer Care Amid Conflict: A Proposal for Optimizing Oncology Services During Wartime
Ahmed, Y. (2023) · JCO Global Oncology · doi:10.1200/go.23.00304 · Cited by 24
Carey, R. N., Hutchings, S. J., Rushton, L., Driscoll, T., Reid, A., Glass, D. C., Darcey, E., Si, S., Peters, S., Benke, G., et al. (2017) · Cancer Epidemiology · doi:10.1016/j.canep.2016.12.009 · Cited by 21
Determinants of cancer screenings participation in Queensland: a scoping review
Lui, P. S. C., Singh, K. P., Nguyen, T., Kurth, B., Phan, T. D., Nelson, A., Danisevska, R., & Ambrosis, T. D. (2023) · Journal of Primary Health Care · doi:10.1071/hc23012 · Cited by 7
Cited by
Artificial Intelligence Advancements in Oncology: A Review of Current Trends and Future Directions
Huhulea, E. N., Huang, L., Eng, S., Sumawi, B., Huang, A., Aifuwa, E., Hirani, R., Tiwari, R. K., & Etienne, M. (2025) · Biomedicines · doi:10.3390/biomedicines13040951 · Cited by 74
“Moreover, disparities in the cancer burden are projected to continue increasing across countries, age, and sex [20].”
Nezenega, Z. S., Aychiluhm, S. B., Ross, A. G., Kassa, Z. Y., Bore, M. G., Leshargie, C. T., Allan, J., Thapa, S., Astawesegn, F. H., Mahmood, S., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-02266-x · Cited by 13
Self-citationRoshid, M. M., Rahman, M. M., Eity, K. F., & Okamura, H. (2026) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyag026 · Cited by 1
Metadata
- Authors
- Bizuayehu, H. M., Ahmed, K. Y., Kibret, G. D., Dadi, A. F., Belachew, S. A., Bagade, T., Tegegne, T. K., Venchiarutti, R. L., Kibret, K. T., Hailegebireal, A. H., Assefa, Y., Khan, M. N., Abajobir, A., Alene, K. A., Mengesha, Z., Erku, D., Enquobahrie, D. A., Minas, T. Z., Misgan, E., & Ross, A. G.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2024-11-05
- Volume
- 7
- Issue
- 11
- Pages
- e2443198
- ISSN
- 2574-3805 (ISSN-L)
- OpenAlex
- W4404061126
- Cited by
- 407
- References
- 27
- FWCI
- 62.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.